Steven McGraw

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

J. Daniel, Evanthia Galanis, S. Keith Anderson et al. · Neuro-Oncology · 2014 · 166 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study

Steven Powell, Kathryn A. Gold, Mark M. Gitau et al. · Journal of Clinical Oncology · 2020 · 119 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

Jann N. Sarkaria, Evanthia Galanis, Wenting Wu et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 89 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).

Steven Powell, Mark M. Gitau, Christopher Sumey et al. · Journal of Clinical Oncology · 2017 · 59 citations

Medicine, Oncology, Pharmacology +17

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Steven Powell, Miroslaw Mazurczak, Elie G. Dib et al. · Investigational New Drugs · 2022 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14